Johnson & Johnson

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Johnson & Johnson
TickerJNJ
CIK #0000200406
CUSIP478160104
SectorLife Sciences - Pharmaceutical Preparations
AddressOne Johnson & Johnson Plz, New Brunswick, NJ 08933
Source [EDGAR]
CIK Filing 2011 - 2025
[0000200406] 10-K
[0000200406] 10-Q
[0000200406] 13F-HR
[0000200406] 13F-NT
[0000200406] 3
[0000200406] 4
[0000200406] 5
[0000200406] 8-K
[0000200406] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Johnson & Johnson Rapport Therapeutics Inc [2024-10-18] 6.8
Johnson & Johnson Rallybio Corp [2024-07-30] 8.8
Johnson & Johnson Contineum Therapeutics Inc [2024-04-10] 10.7
Johnson & Johnson Kenvue Inc [2024-01-24] 0.5
Johnson & Johnson CVRX Inc [2022-02-07] 19.6
State Street Corp Johnson & Johnson [2021-02-12] 5.47
Johnson & Johnson Fusion Pharmaceuticals Inc [2020-07-06] 0.0
State Street Corp Johnson & Johnson [2020-02-13] 5.77
Johnson & Johnson BiomX Inc [2019-11-26] 0.3
Johnson & Johnson MeiraGTx Holdings PLC [2019-03-04] 8.7
State Street Corp Johnson & Johnson [2019-02-13] 5.7
Johnson & Johnson Provention Bio Inc [2019-01-22] 6.4
Johnson & Johnson PhaseBio Pharmaceuticals Inc [2019-01-22] 6.6
State Street Corp Johnson & Johnson [2018-02-14] 5.81
State Street Corp Johnson & Johnson [2017-02-07] 5.65
Johnson & Johnson Merus NV [2017-01-18] 7.4
Johnson & Johnson Tracon Pharmaceuticals Inc [2016-10-31] 6.4
Johnson & Johnson Protagonist Therapeutics Inc [2016-08-19] 15.0
State Street Corp Johnson & Johnson [2016-02-16] 5.4
Johnson & Johnson Aduro Biotech Inc [2016-02-12] 6.2
Johnson & Johnson Catalyst Biosciences Inc [2015-08-28] 0.0
Johnson & Johnson Achillion Pharmaceuticals Inc [2015-07-07] 15.6
State Street Corp Johnson & Johnson [2015-02-12] 5.7
Vanguard Group Inc Johnson & Johnson [2015-02-10] 5.85
Johnson & Johnson Aquinox Pharmaceuticals Inc [2015-02-06] 15.1
Johnson & Johnson GI Dynamics Inc [2015-02-06] 6.0
Johnson & Johnson Nevro Corp [2015-02-05] 12.4
Johnson & Johnson Aldeyra Therapeutics Inc [2015-02-05] 31.4
Johnson & Johnson Macrogenics Inc [2015-02-05] 6.5
Johnson & Johnson Genocea Biosciences Inc [2015-02-05] 8.0
Johnson & Johnson Minerva Neurosciences Inc [2014-07-17] 18.0
State Street Corp Johnson & Johnson [2014-02-03] 5.7
Johnson & Johnson Prothena Corp PLC [2013-02-13] 14.82
State Street Corp Johnson & Johnson [2013-02-11] 5.5
State Street Corp Johnson & Johnson [2012-02-09] 5.1
Form 3/4/5 Filer 2011 - 2025
Johnson & Johnson
Wolk Joseph J
Reed John C
Pinto Daniel E
Woods Eugene A.
Hewson Marillyn A
Weinberger Mark A
McClellan Mark B.
Beckerle Mary C
Doudna Jennifer A
Joly Hubert
West Nadja
Johnson Paula A
Duato Joaquin
Decker Robert J
Taubert Jennifer L
Swanson James D.
Schmid Timothy
Mulholland Kristen
Forminard Elizabeth
Broadhurst Vanessa
Wengel Kathryn E
Davis D Scott
Adamczyk Darius
Mulcahy Anne M
Contineum Therapeutics, Inc.
Johnson & Johnson Innovation - JJDC, Inc.
CVRx, Inc.
Fasolo Peter
Hait William
McEvoy Ashley
Kenvue Inc.
Washington A. Eugene
Mongon Thibaut
Gorsky Alex
MeiraGTx Holdings plc
Prince Charles
Williams Ronald A
Davis Ian
Mammen Mathai
Ullmann Michael H
Stoffels Paulus
Sneed Michael E
Fusion Pharmaceuticals Inc.
Perez William D
Mesquita Jorge S.
Kapusta Ronald A
Provention Bio, Inc.
Inspire Medical Systems, Inc.
Caruso Dominic J
Peterson Sandra E
Achillion Pharmaceuticals Inc
Minerva Neurosciences, Inc.
Pruden Gary J
Lindquist Susan L
Protagonist Therapeutics, Inc
Nevro Corp
Coleman Mary Sue
Neurogene Inc.
Mullin Leo F
Cullen James
Cosgrove Stephen J
Aldeyra Therapeutics, Inc.
Johns Michael M E
Genocea Biosciences Inc
Satcher David
Weldon William C
Deyo Russell C
McCoy Sherilyn S
Universal Biosensors Inc
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2025-06-30] SOLE 0 225,613,998
BlackRock, Inc. [2025-06-30] SOLE 185,159,338 203,849,282
State Street Corp [2025-06-30] DFND 64,121,213 132,797,335
Geode Capital Management LLC [2025-06-30] DFND 60,555,635 60,609,476
JPMorgan Chase & Co [2025-06-30] DFND 47,268,980 55,712,975
Morgan Stanley [2025-06-30] DFND 18,702,473 46,984,867
Norges Bank [2025-06-30] SOLE 31,929,124 31,929,124
Bank of America Corp /DE/ [2025-06-30] DFND 6,735,955 28,296,753
Northern Trust Corp [2025-06-30] DFND 26,354,742 26,703,683
Wellington Management Group LLP [2025-06-30] DFND 0 24,876,538
Bank of New York Mellon Corp [2025-06-30] DFND 19,548,640 23,156,971
State Farm Mutual Automobile Insurance Co [2025-06-30] SOLE 21,832,800 21,832,800
Legal & General Group Plc [2025-06-30] DFND 17,276,331 18,917,274
Charles Schwab Investment Management Inc [2025-06-30] SOLE 18,587,330 18,793,990
Wells Fargo & Company/MN [2025-06-30] DFND 2,135,745 18,290,136
Franklin Resources Inc [2025-06-30] DFND 17,300,555 17,455,744
Dimensional Fund Advisors LP [2025-06-30] SOLE 16,157,123 16,757,236
Deutsche Bank AG [2025-06-30] DFND 7,155,723 15,653,979
Invesco Ltd. [2025-06-30] DFND 0 14,016,955
UBS Group AG [2025-06-30] DFND 5,483,202 13,738,633
FMR LLC [2025-06-30] DFND 7,262,648 13,421,475
Ameriprise Financial Inc [2025-06-30] DFND 0 13,200,118
Royal Bank of Canada [2025-06-30] DFND 12,063,827 13,083,046
Massachusetts Financial Services Co /MA/ [2025-06-30] SOLE 12,572,304 12,679,600
Goldman Sachs Group Inc [2025-06-30] DFND 11,604,821 12,474,859
Vanguard Group Inc [2025-06-30] DFND 16,023 11,433,861
Amundi [2025-06-30] DFND 10,607,433 11,191,098
State Farm Mutual Automobile Insurance Co [2025-06-30] DFND 9,842,692 9,842,692
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] DFND 5,737,974 9,598,355
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 6,581,916 9,541,040
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com